Hostname: page-component-6898cfcb55-zkb6p Total loading time: 0 Render date: 2026-11-11T11:06:55.062Z Has data issue: false hasContentIssue false
  • English
  • Français

The Limits of Serial Surveillance Cultures in Predicting Clearance of Colonization with Carbapenemase-Producing Enterobacteriaceae

Published online by Cambridge University Press:  17 March 2015

Jessica D. Lewis,
Kyle B. Enfield,
Amy J. Mathers,
Eve T. Giannetta and
Costi D. Sifri
Jessica D. Lewis
Affiliation:
Division of Infectious Diseases & International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia
Kyle B. Enfield
Affiliation:
Division of Pulmonary & Critical Care Medicine, Department of Medicine, University of Virginia Health System, Charlottesville, VirginiaOffice of Hospital Epidemiology/Infection Prevention & Control, University of Virginia Health System, Charlottesville, Virginia
Amy J. Mathers
Affiliation:
Division of Infectious Diseases & International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VirginiaDepartment of Pathology, University of Virginia Health System, Charlottesville, Virginia.
Eve T. Giannetta
Affiliation:
Office of Hospital Epidemiology/Infection Prevention & Control, University of Virginia Health System, Charlottesville, Virginia
Costi D. Sifri*
Affiliation:
Division of Infectious Diseases & International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VirginiaOffice of Hospital Epidemiology/Infection Prevention & Control, University of Virginia Health System, Charlottesville, Virginia
*
Address all correspondence to Costi D. Sifri, MD, Division of Infectious Diseases & International Health, Office of Hospital Epidemiology/Infection Prevention & Control, University of Virginia Health System, P.O. Box 800473, Charlottesville, VA 22908-0473 (csifri@virginia.edu).
Rights & Permissions [Opens in a new window]

Abstract

An accepted practice for patients colonized with multidrug-resistant organisms is to discontinue contact precautions following 3 consecutive negative surveillance cultures. Our experience with surveillance cultures to detect persistent carbapenemase-producing Enterobacteriaceae (CPE) colonization suggests that extrapolation of this practice to CPE-colonized patients may not be appropriate.

Infect Control Hosp Epidemiol 2015;36(7):835–837

Information

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 36 , Issue 7 , July 2015, pp. 835 - 837
Copyright
© 2015 by The Society for Healthcare Epidemiology of America. All rights reserved 

Carbapenemase-producing Enterobacteriaceae (CPE) are pathogens of increasing prevalence and worldwide concern.Reference Nordmann, Naas and Poirel 1 The Centers for Disease Control and Prevention (CDC) recommends that institutions in which CPE is endemic perform active surveillance testing and maintain contact precautions for patients infected or colonized with CPE. 2 However, the CDC does not provide guidance regarding discontinuation of contact precautions for these patients. 2 Through retrospective review of our institution’s CPE surveillance program, we sought to determine the utility of serial screening in predicting clearance of CPE colonization.

METHODS

CPE Surveillance and Infection Control Measures

The University of Virginia Health System (UVAHS) is comprised of a 600-bed academic medical center, a 40-bed long-term acute care hospital (LTACH), and numerous primary care and subspecialty ambulatory clinics. In April 2009, in response to CDC guidance, 3 UVAHS initiated CPE surveillance using weekly perirectal cultures for all patients in select intensive care units, at the LTACH, and on all units on which a CPE-positive patient was present. Patients transferred to UVAHS from regions in which CPE is endemic or who were otherwise designated as high-risk for CPE colonization by the hospital epidemiologist were screened on admission. All CPE-colonized or infected patients were maintained on contact precautions, and a long-term indicator was entered in the electronic medical record. To assess for ongoing colonization, follow-up perirectal cultures were collected on known CPE-colonized patients who were not receiving antibacterial medication, no sooner than 8 weeks after the initial positive culture, at an outpatient clinic visit or upon readmission to the hospital.

Subjects

The study period was defined as April 2009, the start of the CPE surveillance program, through August 2013. All UVAHS patients with a positive CPE perirectal culture obtained during the study period were included in this study. Patients with CPE from clinical isolates but without documented perirectal colonization were not included, as negative follow-up perirectal cultures in these patients would incorrectly be interpreted as “cleared” when they in fact had never been perirectally colonized. Recurrence of CPE-positivity was defined as a perirectal or clinical culture positive for carbapenemase production, following at least 1 negative perirectal culture. Patients were counted once and were censored following recurrence. The University of Virginia Institutional Review Board for Health Sciences Research approved this study with waiver of consent.

Microbiology

All clinical Enterobacteriaceae isolates meeting criteria for production or possible production of extended spectrum β-lactamase by automated testing (VITEK 2; bioMérieux, Durham, NC) were phenotypically screened for carbapenemase production using the indirect carbapenemase test, performed as previously described.Reference Mathers, Carroll, Sifri and Hazen 4 bla KPC polymerase chain reaction testing was performed on all isolates with a positive phenotypic test as previously described.Reference Mathers, Carroll, Sifri and Hazen 4 Surveillance cultures were obtained via perirectal swabs and processed as previously described.Reference Mathers, Hazen and Carroll 5

RESULTS

During the study period, 142 patients had at least 1 positive CPE perirectal culture. Patient characteristics are listed in Table 1. A total of 95 patients had at least 1 follow-up perirectal culture. Of these, 51 patients (53.7%) were negative for CPE colonization at the first follow-up culture (Table 2). Of the 51 patients with 1 negative follow-up perirectal culture, 31 patients had a second follow-up culture. The cultures of 24 patients (77.4%) remained negative, and positive cultures recurred in 7 patients. A positive urine culture for Klebsiella pneumoniae, the same organism that had grown on the initial perirectal culture, was recorded in 1 patient. Recurrently positive perirectal cultures were observed in 6 patients; 4 of these patients had recurrent positive cultures with the same organism as their initial positive perirectal culture (3 with K. pneumoniae, 1 with Citrobacter freundii). In the other 2 patients, distinct species other than those previously isolated were detected: K. pneumoniae then K. oxytoca in one case and Enterobacter aerogenes then C. freundii in the other.

TABLE 1

Characteristics of 142 Patients

NOTE. HIV, human immunodeficiency virus; AIDS, acquired immunodeficiency syndrome; CPE, carbapenemase-producing Enterobacteriaceae.

a Includes 16 liver, 6 kidney, 1 kidney-pancreas, and 2 lung transplant patients.

TABLE 2

Predictive Value of Negative Cultures

Of the 24 patients with 2 consecutive negative follow-up perirectal cultures, 20 patients had a third follow-up culture; 17 of these patients (85.0%) remained negative. In 1 patient, a urine culture grew K. pneumoniae, which had grown on the initial perirectal culture. Positive perirectal cultures growing species distinct from those with which they were initially colonized occurred in 2 patients: C. freundii then Serratia marcescens in one case and E. aerogenes then E. cloacae in the other.

Of the 17 patients with 3 consecutive negative follow-up perirectal cultures, additional culture data were available for 8 patients. Of these, 6 patients (75.0%) remained CPE-negative on all subsequent cultures (ranging from 1 to 9 additional cultures) for the duration of the study. In 1 patient, bla KPC -positive Citrobacter, which we were unable to speciate by 16S rRNA sequencing, recurred on perirectal culture nearly 8 months after an initial perirectal culture positive for E. cloacae and 7.5 months after the first of 3 negative CPE perirectal cultures. In a second patient, CPE recurred after 5 consecutive negative screens. Although this patient was initially perirectally colonized with K. oxytoca, K. pneumoniae recurred on perirectal culture in this patient 4 months later and 6 weeks after the first of 5 negative perirectal cultures.

DISCUSSION

The CDC supports discontinuation of contact precautions for patients colonized or infected with methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant Enterococcus (VRE) following 3 consecutive negative surveillance cultures obtained while the patient is not receiving antimicrobial therapy,Reference Siegel, Rhinehart, Jackson and Chiarello 6 and data validating this practice exists. For example, Byers et alReference Byers, Anglim, Anneski and Farr 7 demonstrated that, in patients previously documented to be colonized with VRE, 95% of patients with 3 consecutive negative surveillance cultures and 100% of patients with 4 consecutive negative surveillance cultures remained negative at their next follow-up screening culture.

Few data are available on the natural history of CPE colonization and the predictive utility of CPE surveillance cultures. In a prospective study from Israel, relapse of CPE carriage occurred in 5 of 50 prior CPE carriers (10%) after 3 consecutive negative surveillance cultures.Reference Feldman, Adler and Molshatzki 8 In another recent study, despite treatment with oral gentamicin and/or colistin, 8 of 50 patients (16%) had recurrence of CPE colonization after achieving eradication, defined as 3 consecutive negative perirectal swabs.Reference Oren, Sprecher and Finkelstein 9 Similar to the findings of these groups,Reference Feldman, Adler and Molshatzki 8 , Reference Oren, Sprecher and Finkelstein 9 we found a 25% recurrence rate of CPE colonization after 3 or more consecutive negative perirectal cultures.

Our study has several limitations. First, this study was not adequately powered to delineate the risk factors for persistent colonization. Second, we cannot definitively state whether positive CPE surveillance cultures after prior negative perirectal cultures were due to variation in specimen collection techniques, true recurrence caused by re-exposure to a CPE-colonized patient or environment, or persistent colonization at a burden below the limit of detection of our assay that emerged following antibiotic exposure. Notably, we have previously observed co-colonization with multiple species of CPE in the same patient.Reference Mathers, Cox and Kitchel 10 In some cases, both strains of CPE have been found to carry the same bla KPC -positive plasmid.Reference Mathers, Cox and Kitchel 10 Thus, recurrence of CPE-positivity with a species distinct from that with which the patient was initially colonized is not necessarily indicative of reinfection but may be secondary to relapse, as a consequence of horizontal transmission of a bla KPC -positive plasmid between different species of Enterobacteriaceae. Given the limited sample size of our study and its retrospective nature, larger prospective studies are needed to reach more definitive conclusions about the natural history of CPE colonization and the utility of surveillance cultures to predict clearance of colonization. Our study suggests that the extrapolation of data used to support discontinuation of contact precautions for patients colonized with MRSA or VRE is not sufficient to determine when contact precautions can safely be discontinued for CPE-colonized patients, as this practice may be associated with an unacceptably high risk of relapse and exposure of other patients to these highly resistant pathogens.

Acknowledgments

Financial support. This study was supported by a National Institutes of Health Infectious Disease Training Grant (no. 5T32AI007046-37).

Potential conflicts of interest. All authors report no conflicts of interest relevant to this article.

References

1. Nordmann, P, Naas, T, Poirel, L. Global spread of carbapenemase-producing Enterobacteriaceae . Emerg Infect Dis 2011;17:1791–1798.CrossRefGoogle ScholarPubMed
2. Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE)—2012 CRE Toolkit. Centers for Disease Control and Prevention website. http://www.cdc.gov/hai/organisms/cre/cre-toolkit/. Published 2013. Accessed July 25, 2013.Google Scholar
3. Centers for Disease Control and Prevention. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. Morbid Mortal Weekly Rept 2009;58:256–260.Google Scholar
4. Mathers, AJ, Carroll, J, Sifri, CD, Hazen, KC. Modified Hodge test versus indirect carbapenemase test: prospective evaluation of a phenotypic assay for detection of Klebsiella pneumoniae carbapenemase (KPC). in Enterobacteriaceae. J Clin Microbiol 2013;51:1291–1293.Google Scholar
5. Mathers, AJ, Hazen, KC, Carroll, J, et al. First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the “menace” arrives in the new world. J Clin Microbiol 2013;51:680–683.Google Scholar
6. Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L, the Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. Centers for Disease Control and Prevention website. http://www.cdc.gov/hicpac/pdf/MDRO/MDROGuideline2006.pdf. Published 2006. Accessed October 31, 2014.Google Scholar
7. Byers, KE, Anglim, AM, Anneski, CJ, Farr, BM. Duration of colonization with vancomycin-resistant Enterococcus . Infect Control Hosp Epidemiol 2002;23:207–211.CrossRefGoogle ScholarPubMed
8. Feldman, N, Adler, A, Molshatzki, N, et al. Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage. Clin Microbiol Infect 2013;19:E190–E196.CrossRefGoogle ScholarPubMed
9. Oren, I, Sprecher, H, Finkelstein, R, et al. Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: a prospective controlled trial. Am J Infect Control 2013;41:1167–1172.Google Scholar
10. Mathers, AJ, Cox, HL, Kitchel, B, et al. Molecular dissection of an outbreak of carbapenem-resistant Enterobacteriaceae reveals intergenus KPC carbapenemase transmission through a promiscuous plasmid. MBio 2011;2:e00204–e00211.CrossRefGoogle ScholarPubMed
Figure 0

TABLE 1Characteristics of 142 Patients

Figure 1

TABLE 2Predictive Value of Negative Cultures